Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 80425-0396

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 80425-0396). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Venlafaxine 75mg #30 (Venlafaxine HCl Er 75mg 80425 0396 01)

Venlafaxine Hydrochloride 75 mg extended release capsules packaging label from Advanced Rx Pharmacy of Tennessee, LLC. The label includes dosing strength, comparison to Effexor XR, NDC numbers, lot number placeholder, and expiration date of 5/31/2025. The package contains 30 capsules.*

FDA Label Image

Venlafaxine 75mg #60 (Venlafaxine HCl Er 75mg 80425 0396 02)

Venlafaxine Hydrochloride 75 mg extended release oral capsules in a prescription bottle. The label shows the proprietary name, strength, and dosage form. It includes lot number and expiration date (05/31/2025). The product is labeled by Advanced Rx Pharmacy of Tennessee, LLC with NDC 80425-0396, and there is a reference to EPIC PHARMA LLC as well.*

FDA Label Image

Venlafaxine 75mg #90 (Venlafaxine HCl Er 75mg 80425 0396 03)

Venlafaxine HCl ER 75 mg capsule label from Advanced Rx Pharmacy of Tennessee, LLC. The label includes storage instructions (20-25°C), a barcode, NDC numbers (80425-0396 and source 42806-0602-09), and an expiration date of 5/31/2025. It states Rx Only and compares to Effexor XR, with a lot number placeholder.*

FDA Label Image

Image-01 (Image 01)

Chemical structure of venlafaxine hydrochloride, showing the molecule's specific arrangement including a cyclohexane ring, a methoxy-substituted benzene ring, and a dimethylamino group linked to a central carbon with an attached hydroxyl group and hydrochloride salt.*

FDA Label Image

Image-02 (Image 02)

A scatter plot chart displaying fold change and 90% confidence intervals for venlafaxine and its metabolite ODV across various special populations including hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism, age over 60 years, and gender. The x-axis represents change relative to the reference value, with plotted points indicating Cmax and AUC pharmacokinetic parameters for each group.*

FDA Label Image

Image-03 (Image 03)

A dot plot chart showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of venlafaxine and its metabolite ODV when interacting with various drugs including ethanol, diazepam, cimetidine, ketoconazole (in CYP2D6 EM's and PM's), indinavir, metoprolol, imipramine, and lithium. The x-axis indicates change relative to the reference value ranging from 0 to 3.*

FDA Label Image

Image-04 (Image 04)

A forest plot chart showing the fold change and 90% confidence intervals for various analytes related to interacting drugs, including ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The horizontal axis represents change relative to a reference value, and the plot compares Cmax and AUC pharmacokinetic parameters for these analytes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.